WELCOME TO The Biotechnology REPORT
Newsletter | Member Login | Signup
Home > Resources > Whitepapers > Use of PS-DVB Columns and Matched Buffers in the Purification and Scale-Up of mRNA Drug Candidates
August 24, 2022
I'm For Real
Enter your details once to access all our information and resources
Transgene (Euronext : TNG), qui fait partie de l’Institut Mérieux, est une société de biotechnologie qui conçoit et développe des produits d’immunothérapie ciblée contre les cancers et les maladies infectieuses.
whitePaper | May 26, 2022
Exploring biomarkers with the new central dogma. It can be a daunting decision for scientists to know when to focus on DNA, messenger RNA (mRNA), non-coding RNA (ncRNA) or protein biomarkers for routine clinical use, with each exhibiting its own strengths and limitations
whitePaper | November 18, 2022
Due to vaccine delivery gap for Rubella disease, global immunization is still limited in some parts of the world. In this paper we will demonstrate how one scale-X™ carbo fixed-bed bioreactor system.
whitePaper | November 12, 2019
This document describes a novel Quanterix lysate diluent for running lysate samples with Simoa assays diluent.
whitePaper | October 20, 2022
We began the project by working to the design of a recombinant bacterial strain selection of a strain capable of producing high concentrations of peptides.
whitePaper | June 8, 2022
Cardinal Health is fortunate to sit at the crossroads of the United States (U.S.) healthcare system, engaging with stakeholders from across the industry including healthcare
whitePaper | July 30, 2021
Clinical trials are complex, lengthy, and resource-inefficient. The clinical research industry is responsible for the delivery of medical solutions to society by systematically evaluating their safety and efficacy in humans during so-called clinical trials. As exemplified by the COVID-19 pandemic, a steady and efficient influx of vaccines, therapeutics, and other innovative medical solutions is critical for meeting society’s current and future medical needs. Unfortunately, the industry faces several persistent issues that make clinical trial operations overly complex, lengthy, and resource-inefficient.
Conference
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE